Business Details
Your Partner in Non-Invasive Medical Solutions
RST-SANEXAS has pioneered non-invasive, non-pharmaceutical treatment solutions for pain management and rehabilitation for over 35 years. Our Electric Cell-Signaling Technology (EcST) combines quantum physics principles with advanced electronic engineering to deliver targeted therapeutic energy through harmonically structured signals. We hold foundational patents in sequentially generated multi-parameter bio-electric delivery systems and have received FDA clearances for treating post-traumatic pain, chronic pain, and circulatory conditions. Our team provides comprehensive training and continuing education programs for healthcare professionals, including EcST certification support. With in-house U.S. manufacturing capabilities and a dual-location approach to quality control, we ensure precision and performance in every device.Our commitment to innovation extends to complementary modalities like red/infrared light therapy and therapeutic vibration systems. We maintain rigorous compliance with ISO 13485 standards and MDSAP certification for medical device quality management. Our research-driven approach incorporates Schumann resonance, Solfeggio frequencies, and Fibonacci sequencing to optimize biological resonance. We support providers with clinical resources, patient protocols, and technical troubleshooting while maintaining a 24/7 customer service line for urgent inquiries. Our growth strategy focuses on expanding home-use concepts and delivery methods that align with our frequency-based therapeutic approach.
Services
neoGEN System
SynRG Lights Series
Contract Manufacturing
Distributorships
After Care Products
Highlights and features
- 35+ years developing patented Electric Cell-Signaling Technology
- FDA-cleared devices for pain management and circulatory support
- Comprehensive EcST certification training programs available
- In-house U.S. manufacturing with German engineering standards
- Research incorporates quantum physics and biological resonance principles
What people say
Changing my life
Most amazing breakthrough device
Restored function and balance
Reduced gabapentin use
Improved quality of life
Services
neoGEN System
The neoGEN System delivers Electric Cell-Signaling energy waves through advanced technology for non-invasive pain management. This FDA-cleared medical device treats chronic pain, post-surgical conditions, and neuromuscular disorders by applying harmonically structured signals that interact with physiological rhythms. Its multi-layered approach combines amplitude modulation, frequency modulation, and spread-spectrum technology to optimize therapeutic effectiveness.
SynRG Lights Series
SynRG Lights Series provides red and infrared light therapy for therapeutic support through FDA-registered devices. These systems deliver specific wavelengths to improve circulation, reduce inflammation, and support tissue recovery. The product line includes full-body beds, targeted panels, and specialized devices like the Foot Revitalizer, all designed for clinical and home use with adjustable intensity settings.
Contract Manufacturing
Our contract manufacturing services combine U.S.-based production capabilities with German engineering standards for medical device manufacturing. We maintain ISO 13485 certification and MDSAP compliance while offering scalable production solutions for frequency-based therapeutic technologies. Our facilities support both prototype development and large-scale manufacturing of electrotherapeutic equipment with strict quality control measures.
Distributorships
We offer distributorship opportunities for healthcare professionals seeking to provide advanced non-invasive treatment solutions. Our program includes comprehensive training on Electric Cell-Signaling Technology, marketing support, and clinical implementation guidance. Distributors gain access to a full product portfolio including the neoGEN Series and SynRG Lights devices with dedicated technical support.
After Care Products
Our aftercare product line includes therapeutic vibration devices, topical analgesics, and thermal therapy solutions designed to complement primary treatments. The Body and Foot Massagers use oscillatory stimulation to improve circulation, while nitric oxide supplements and hot/cold gel packs support post-treatment recovery. All products meet FDA Class I medical device standards for safety and effectiveness.
Questions
What conditions does the neoGEN System treat?
The FDA-cleared neoGEN System treats post-traumatic pain syndromes, chronic intractable pain, post-surgical pain, muscle spasms, and circulation issues through Electric Cell-Signaling Technology.
How does Electric Cell-Signaling Technology work?
Our technology combines amplitude modulation, frequency modulation, and spread-spectrum signaling to deliver dynamic energy patterns that interact with nerve cell membranes and voltage-gated ion channels.
Are your devices available for home use?
We're developing home-use concepts while currently focusing on clinical applications. The neoGEN Basic offers a compact solution for professional settings.
Do you offer training for healthcare providers?
Yes, we provide comprehensive EcST certification programs, patient protocol guidance, and continuing education for medical professionals implementing our technology.
What complementary therapies do you offer?
Our SynRG Lights Series includes red/infrared light therapy devices and therapeutic vibration systems that work synergistically with Electric Cell-Signaling Technology for enhanced treatment outcomes.
Reviews (2)
J. J.
Oct 30, 2021
Report
Great product. Will say it does not work for everyone. But's that life. Nothing is 100%. I think there is a little room for improvement, but still is a very good product. I'm glad my dad can walk easier.
Morhea Technologies
Dec 27, 2020
Report
After years of chronic pain problems and the forced loss of my job, I was introduced to the RST-Sanexas machine by my Pain Physician. After two weeks, I have nearly no contant pain and am returning to my construction profession. Thank God for this innovation.
